Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
HelpMeSee’s Mazava Project trains general practitioners in Madagascar to perform cataract surgeries, addressing the country’s ...
Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback